<p>Dr Richard M Stone from Dana-Farber Cancer Institute in Boston discusses the optimal selection and sequencing of systemic therapies for patients with acute myeloid leukemia and myelodysplastic syndromes.</p>

Dr Richard M Stone from Dana-Farber Cancer Institute in Boston discusses the optimal selection and sequencing of systemic therapies for patients with acute myeloid leukemia and myelodysplastic syndromes.

Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series

Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.

Share Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series

Sign up to save your podcasts

Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series

Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series

More shows like Hematologic Oncology Update

JAMA Editors' Summary

Gastrointestinal Cancer Update

Lung Cancer Update

Prostate Cancer Update

Breast Cancer Update

Gynecologic Oncology Update

Dermatologic Oncology Update

NEJM This Week

Research To Practice | Oncology Videos

The Hematologist

JAMA Clinical Reviews

Annals On Call Podcast

Blood Podcast

Oncology Today with Dr Neil Love

WolverHeme Happy Hour

Two Onc Docs

Blood Cancer Talks